Evaluating the Efficacy and Safety of NEOadjuvant CHEmoimmunotherapy in Early ER-Low/HER2-Negative Breast Cancer (NEOCHEER): A Systematic Review and Meta-Analysis

Post time Yesterday 03:44

journal：Clinical Breast Cancer

Authors：Jessé Lopes da Silva; Luís Felipe Leite da Silva; Wallace Klein Schwengber; Lucas Zanetti de Albuquerque; Natália Cristina Cardoso Nunes; Andréia Cristina de Melo

Published date：2026-2-

DOI：10.1016/j.clbc.2025.09.017

PDF link：https://www.sciencedirect.com/sc ... 526820925002861/pdf

Article link：https://doi.org/10.1016/j.clbc.2025.09.017

Article Source：Elsevier BV。

Remark：

Post time Yesterday 03:44

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Evaluating the Efficacy and Safety of NEOadjuvant CHEmoimmunotherapy in Early ER-Low/HER2-Negative Breast Cancer (NEOCHEER): A Systematic Review and Meta-Analysis

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Evaluating the Efficacy and Safety of NEOadjuvant CHEmoimmunotherapy in Early ER-Low/HER2-Negative Breast Cancer (NEOCHEER): A Systematic Review and Meta-Analysis Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Evaluating the Efficacy and Safety of NEOadjuvant CHEmoimmunotherapy in Early ER-Low/HER2-Negative Breast Cancer (NEOCHEER): A Systematic Review and Meta-Analysis